← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2014Last known activity
Sep 1, 2025
Timeline
1940s
- Jan 1, 1947
Liaocheng People's Hospital— Founded
Drugs by trial phase (37 distinct, 21 trials)
Phase 4 (16 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Brain Diseases
- Carbon Monoxide Poisoning
- Colitis
- Colitis, Ulcerative
- Disease Susceptibility
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Hypersensitivity
- Hypertension
- Hypertension, Pulmonary
- Intracranial Arteriosclerosis
- Intracranial Embolism
- Intracranial Thrombosis
- Leprosy
- Osteoarthritis
- Osteoarthritis, Knee
- Pneumonia, Pneumocystis
- Poisoning
- Purpura, Thrombocytopenic, Idiopathic
- Skin Diseases
- Skin Diseases, Vesiculobullous
- Thrombocytopenia
- Ulcer
- Urticaria
- Vasculitis
- Vasculitis, Leukocytoclastic, Cutaneous
Recent trials (31)
- NCT06902740CollaboratorPhase 4Sep 1, 2025
- NCT06302582Lead sponsorPhase 1/Phase 2Feb 29, 2024
- NCT05965687CollaboratorPhase 3Aug 17, 2023
- NCT05981079CollaboratorPhase 4Jul 31, 2023
- NCT05901779CollaboratorN/AApr 1, 2023
- NCT05586464Lead sponsorPhase 1Nov 1, 2022
- NCT05549115Lead sponsorN/ASep 20, 2022
- NCT05549115Study chairN/ASep 20, 2022
- NCT06823791Sponsor investigatorPhase 1/Phase 2Aug 1, 2022
- NCT06823791Lead sponsorPhase 1/Phase 2Aug 1, 2022
- NCT05236621Overall official - principal investigatorPhase 3Jan 4, 2021
- NCT05236621OfficialPhase 3Jan 4, 2021
- NCT04976543CollaboratorPhase 4Jan 1, 2020
- NCT04055415Study chairPhase 1/Phase 2Aug 1, 2019
- NCT04055415Lead sponsorPhase 1/Phase 2Aug 1, 2019
Details
- Founded
- Liaocheng, CN Jan 1, 1947
- Last known activity
- Sep 1, 2025